Measles-containing-vaccine second-dose (MCV2) immunization coverage in Algeria
Algeria: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 92.0% in 2025. ▼ Falling
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Algeria, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Algeria stood at 92.0%.
Compared with earlier readings it is up 2.2% on the previous year and down 7.1% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Algeria peaked at 99.0% in 2014 and was at its lowest, 71.0%, in 2022.
Algeria ranks 56th of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 26 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 91.5% | 73.0% | 98.0% | 10 |
| 2010s | 91.8% | 76.0% | 99.0% | 10 |
| 2020s | 82.2% | 71.0% | 93.0% | 6 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Heat deaths vs projected death rates 943.1 (2090)
- Un projection of annual infant deaths 1,455 (2100)
- Population ages 65 and above, total, annual growth rate 4.77 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.0681 units per person (2025)
- Population, female, annual growth rate 1.35 % change on previous year (2025)
- Population, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population, female, per capita 0.4901 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Algeria?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Algeria was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Algeria?
- The highest recorded value was 99.0% in 2014.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Algeria?
- The lowest recorded value was 71.0% in 2022.
- How does Algeria rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Algeria ranks 56th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Algeria?
- Over the last ten years it is down 7.1%. The long-run trend across the full record is falling.
- Where does this Algeria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).